Proclara Biosciences

222, Third St
MA 02142 Cambridge - USA Website

Key figures

Creation date : 2008
Number of employees : 18
Fund name : Mérieux Participations 1

Company presentation

Proclara is pioneering a new approach to treating neurodegenerative diseases. By developing novel therapies that recognize and target multiple misfolded proteins, we aim to make a transformative impact on the lives of patients affected by Alzheimer’s, Parkinson’s, and other diseases caused by protein misfolding. Our approach is shaped by an experienced team with deep drug development experience, and productive collaborations with world-class advisors and partners.

Product and service

.